ARK Investment Management LLCARK Investment Management LLC

Institutional investor · Portfolio as of Q1 2026

SEC EDGAR SourceSEC Filings

Top Holdings182 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

TESLA INC

2.8M$1.1B8.2%$237.50+44.11%
30 qtrssince 2018-Q4
Decreased
0

ADVANCED MICRO DEVICES

2.7M$551.9M4.3%$144.23+256.65%
13 qtrssince 2023-Q1
Increased
61

CRISPR THERAPEUTICS AG

11.3M$538.2M4.2%$63.57-15.77%
30 qtrssince 2018-Q4
Increased
62

SHOPIFY INC - CLASS A

4.2M$495.6M3.9%$48.15+220.47%
30 qtrssince 2018-Q4
Increased
60

PALANTIR TECHNOLOGIES INC-A

3.1M$454.9M3.5%$16.89+930.58%
12 qtrssince 2023-Q2
Decreased
0

Tempus AI, Inc. Class A

9.6M$434.5M3.4%$45.17+15.35%
8 qtrssince 2024-Q2
Increased
71

CIRCLE INTERNET GROUP INC

4.5M$430.2M3.3%$147.21-51.36%
4 qtrssince 2025-Q2
Increased
62

ROBINHOOD MARKETS INC - A

6M$416M3.2%$32.59+193.24%
19 qtrssince 2021-Q3
Increased
70

COINBASE GLOBAL INC -CLASS A

2.4M$414.3M3.2%$150.31-1.23%
20 qtrssince 2021-Q2
Decreased
0

TERADYNE INC

1.2M$369.1M2.9%$111.22+276.54%
30 qtrssince 2018-Q4
Decreased
0

ROKU INC

3.8M$361.5M2.8%$120.60+30.74%
28 qtrssince 2019-Q2
Decreased
0

ROBLOX CORP -CLASS A

5.9M$333.5M2.6%$49.75-23.15%
21 qtrssince 2021-Q1
Increased
64

Twist Bioscience Corp.

6.3M$301.4M2.3%$58.84+101.52%
28 qtrssince 2019-Q2
Decreased
0

BEAM THERAPEUTICS INC

12.1M$289.1M2.2%$50.18-46.69%
22 qtrssince 2020-Q4
Decreased
0

AMAZON.COM INC

1.4M$282.3M2.2%$205.95+27.53%
30 qtrssince 2018-Q4
Increased
59

10x Genomics Inc Class A

11.7M$248.8M1.9%$43.26+29.65%
24 qtrssince 2020-Q2
Decreased
0

KRATOS DEFENSE & SECURITY

3.5M$246.2M1.9%$30.45+112.07%
30 qtrssince 2018-Q4
Increased
49

BULLISH

6.6M$234.5M1.8%$46.70-47.77%
3 qtrssince 2025-Q3
Increased
63

DEERE AND CO

399,074$224.8M1.7%$425.93+42.95%
30 qtrssince 2018-Q4
Decreased
0
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

627,704$212.1M1.6%$192.29+121.73%
12 qtrssince 2023-Q2
Decreased
0
$12.9B
AUM
182
Positions
Q1 2026
Filing
Rating · 4.0
Quarterly Portfolio Change
+10%Q4'24$12B-17%Q1'25$10B+37%Q2'25$13.6B+23%Q3'25$16.8B-10%Q4'25$15.1B-15%Q1'26$12.9B
Activity profile
$ moved · Q1'26
New4%Increased31%Decreased54%Exited12%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 4.8 years
<1Q5%1-4Q8%1-2Y5%2Y+81%

ARK Investment Management LLC manages $12.9B across 182 positions as of Q1 2026. Top holdings: TSLA (8.2%), AMD (4.3%), CRSP (4.2%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 4/5.0.

Q1 2026 Summary

Active quarter - 13 new positions, 28 exits, 86 increased. Top move: TEM (INCREASED, conviction 71). Portfolio: $12.9B across 182 positions.

Top holdings by portfolio weight

Total AUM$13B
TSLA8.19%
AMD4.29%
CRSP4.19%
SHOP3.85%
PLTR3.54%
TEM3.38%
CRCL3.35%
HOOD3.24%
COIN3.22%
TER2.87%
Other2.81%

Portfolio allocation by GICS sector

Sectors11
Technology28.25%
Healthcare24.61%
Consumer Cyclical12.39%
Financial Services12.03%
Industrials11.26%
Communication Services9.77%
Unknown1.23%
Energy0.31%
Utilities0.14%
Basic Materials0.01%
Other0.01%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Healthcare, Consumer Cyclical
Compare DNA across all funds
7-dimension quality assessment
Strong(4.0 / 5.0)
Track RecordNo data
Conviction44
Concentration59
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
GOOGGOOGALPHABET INC-CL C
Q3 2024 Q2 2026+915,979 shares+$345.3M
6Q
AVAVAVAVAEROVIRONMENT INC
Q1 2025 Q2 2026+343,875 shares+$59.7M
6Q
ISRGISRGINTUITIVE SURGICAL INC
Q1 2025 Q2 2026+50,925 shares+$17.8M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used